The blood-brain-barrier (BBB), a network of tight junctions that impedes large molecule transport, limits the usefulness of systemic chemotherapeutic delivery for the treatment of malignant gliomas and other neurological diseases. Here, we present a tool for BBB disruption that uses bursts of sub-microsecond bipolar pulses to enhance the transfer of large molecules to the brain. Blunt needle electrodes were advanced into the motor cortex of anesthetized adult rats, and a series of 90-900 bursts were delivered with voltage-to-distance ratios of 250 or 2000 V/cm, a total programmed energized time of 100 µs, and a repetition rate of 1 Hz. BBB disruption was assessed via a gadolinium-Evans blue albumin tracer, and all experimental conditions were found to cause BBB disruption immediately following treatment without inducing local or distal muscle contractions. The lowest energy condition, 300 bursts consisting of 850 ns bipolar pulses, resulted in signifi cant BBB disruption (0.51 cm 3
INTRODUCTION
Currently, there is no eff ective therapy for malignant glioma. By nature of their neuro-invasiveness, high-grade variants of gliomas are diffi cult to treat and generally considered incurable with singular or multimodal therapies [1] [2] [3] [4] . One reason for poor survival is that treatment may be limited by ineffi cient intracellular delivery of chemotherapy. Most agents demonstrating in vitro cytotoxic eff ects against glial tumors do not cross the blood-brain-barrier (BBB) in vivo. Although the BBB is compromised in portions of high-grade gliomas that are associated with leaky blood vessels, there is evidence that these heterogeneous tumors contain areas of infi ltrative tumor with an intact BBB that limits the eff ectiveness of systemic chemotherapeutics 5, 6 . Techniques that uniformly increase BBB permeability and delivery of low-dose cytotoxic agents into tumors may yield improved tumor control 7, 8 . Conventional osmotic agents or receptor-mediated mechanisms of BBB disruption result in widespread, non-targeted eff ects that can be associated with adverse events 9 . For example, when a bradykinin analog was used to disrupt the BBB in a Phase II trial for childhood brain tumors, the chosen dosage did not improve chemotherapeutic effi cacy, and the patients experienced frequent headaches, fl ushing, and vomiting due to bradykinin 10 . Alternatively, focused ultrasound has emerged as a physical method to temporarily open the BBB 11 . Th e procedure involves systemic injection of gas fi lled microbubbles and transcranial delivery of acoustic energy focused at the target tissue 12 . It is thought that ultrasound induces oscillations in the microbubbles that safely open tight junctions in the blood vessel walls through mechanical stretching. Despite the non-invasive nature of the procedure, beam focusing reduces the coverage area of individual treatments, resulting in extended treatment times for large volumes 13 . Here, we investigate an alternative to chemical and acoustic modalities that utilizes electric fi elds. Previously, it was discovered that a series of short duration (~100 μs) high amplitude (~1000 V/cm) unipolar electric pulses could induce irreversible electroporation (IRE) of cell membranes without causing signifi cant thermal eff ects 14, 15 . Th is technology was 1 Bioelectromechanical Systems Lab, School of Biomedical Engineering and Sciences, Virginia Tech-Wake Forest University, Blacksburg, VA, USA. successfully adapted for non-thermal tumor ablation, including malignant glioma 16, 17 . Minimally invasive needle electrodes were inserted through a defect in the skull to direct the pulse application. While investigating the eff ects of IRE on brain tissue, it was revealed that sub-lethal pulse parameters resulted in transient disruption of the BBB due to reversible electroporation 18, 19 . One challenge with delivering unipolar electric pulses for nonthermal ablation or BBB disruption is that they result in signifi cant muscle contractions 20 . As electrically induced movement could compromise electrode positioning, IRE procedures typically require that patients receive a neuromuscular blocker and general anesthesia. Preliminary studies suggest that this requirement may be removed by designing pulses that alternate in polarity. When bipolar bursts of pulses with individual durations of 2 µs or less were applied to the sensorimotor cortex of rats, it was noted that non-thermal ablation could be achieved without inducing muscle contractions 21 . To the best of our knowledge, these types of pulses have not been studied in vivo for BBB disruption.
In this study, a custom pulse generator capable of delivering bipolar bursts of pulses as short as 500 ns was used to explore if sub-lethal BBB disruption can be achieved without causing muscle contractions. Th ese Vascular Enabled Integrated Nanosecond (VEIN) pulse treatments were performed in normal rat brain by varying the pulse duration within a burst, the total number of bursts, and the applied fi eld. BBB disruption was assessed using an Evans blue-albumin (EBA) complex uptake on histological sections and a gadolinium-EBA complex uptake on MRI scans. Muscle contractions were monitored visually and with an accelerometer placed along the dorsum. Applying 300 bursts containing pulses of 850 ns resulted in BBB disruption without any electrically induced muscle contractions or cell death. Th erefore, this technique has the potential to be performed clinically under conscious sedation without neuromuscular blockade.
METHODS

Animals and intracranial VEIN pulse delivery procedure
All study procedures were approved by the Institutional Animal Care and Use Committee approval (10-163-CVM). Eighteen male Fischer 344 rats weighing 190-225 g were pre-medicated with buprenorphine (0.02 mg/kg subcutaneously) and then anesthetized with inhaled isofl uorane delivered via induction chamber. Anesthesia was maintained with inhaled isofl uorane delivered through a nose cone; provision of a surgical plane of anesthesia was assessed by loss of the tail or toe pinch refl ex. A 3-axis accelerometer breakout board (Adafruit Industries ADXL335), capable of sensing muscle contractions up to 3 g and fi tted with low-pass fi lter capacitors (0.1 µF) at the x, y, and z outputs for noise reduction, was secured to the dorsum of each rat at the cervicothoracic junction using 5-0 monocryl suture. Th e hair of the skull was clipped and aseptically prepared using povidone-iodine and alcohol solutions. Anesthetized rats were placed in a small animal stereotactic head frame (Model 1530M, David Kopf Instruments, CA, USA). A routine, right unilateral rostrotentorial surgical approach to the skull was made and a 1.5 mm × 5 mm rectangular craniectomy defect was created in the skull of each rat using a high-speed electrical drill. Th e rostral aspect of the craniectomy was created at the following stereotactic location relative to the bregma: 4 mm posterior and 3.5 mm lateral and extended caudally. Th e exposed dura was punctured with scalpel blade or hypodermic needle, and the electrodes were then advanced to a depth of 1.5 mm beneath the surface of dura using the manipulator arm of the stereotactic frame. Th e electrodes used for pulse delivery were blunt-tipped electrodes (0.45 mm Ø, 0.4 cm spacing, and 1.0 mm exposure) as previously described 18 . The pulse parameters delivered to rodents are summarized in Table 1 . Th e applied voltage-to-distance ratios across the 0.4 cm gap are used to defi ne the electric fi eld, even though it is understood that needle electrodes produce a non-uniform distribution. Waveforms were generated using an arbitrary function generator (AFG3011, Tektronix Inc., Beaverton, Oregon) to trigger a custom-built high voltage pulse generator capable of delivering ± 1000 V (Applied Energetics, Tucson, AZ, USA). Output waveforms were visualized using an oscilloscope (TDS1002b, Tektronix Inc., Beaverton, Oregon) paired with a 50 MHz, 1000× high voltage probe (P5210A, Tektronix Inc., Beaverton, Oregon) and a 50 MHz clamp on current probe (TCP305A, Tektronix Inc., Beaverton, Oregon). Short circuit protection resistors on the output limited our maximum output voltage to approximately 800 V (2000 V/cm). An example waveform from Group 2 is shown in Fig. 1 . In each trial, the bursts were applied once per second, and the burst on-time was held constant (100 μs) by varying the number of pulses within each burst (i.e., shorter pulse durations require more pulses to achieve the desired on-time). Data from the experiments was analyzed using MATLAB (Version R2013a, Th e MathWorks Inc., Natick, MA). An algorithm was used to calculate the average amplitude of the pulses. Th en, time points corresponding to one half of the pulse amplitude were found, and the pulse width was calculated as the full width at half maximum.
In all rats, 5 minutes prior to delivery of the pulses, 2.5 ml of 2.5% Evans blue solution was delivered via intraperitoneal injection and bound to albumin in the blood (67 kDa) to form the EBA complex 22 . Select rats subjected to MRI examinations received 2.5 ml of gadolinium-EBA (Gd-EBA) solution (74 kDa). Both formulations are considered high molecular weight tracers designed to mimic the diff usion properties of polar protein drugs (growth factors, antibodies, genetic vectors). Th e Gd-EBA solution was prepared by diluting a stock solution of 25 mg/ml Gd-albumin (Galbumin, BioPAL Inc., Worcester, MA, USA), containing 10-15 Gd-DTPA per albumin molecule, with deionized water to a concentration of 10 mg/ml. Th e Gd-albumin was then mixed with EB (1 mg Evans Blue (Sigma, St. Louis, MO, USA) per 2 ml Gd-albumin) to make the tagged Gd-EBA complex. Following completion of the pulse delivery, 15 minutes were allowed to lapse prior to withdrawal of the electrodes from the brain. Following removal of the electrodes, rats were euthanatized by intraperitoneal injection of 1 mL of phenytoin-pentobarbital solution (Beuthanasia-D, Abbott Laboratories, Abbott Park, IL, USA) followed by cervical dislocation. Th e brains were harvested and processed as described below.
Ex vivo brain magnetic resonance imaging (MRI) examinations
Select rats which received IP Gd-EBA were subjected to ex vivo MRI examination of the brain in situ within 15 minutes of euthanasia using a 1.5-T superconducting magnet (Philips Intera, Philips Healthcare, Andover, MA, USA) with an 8-channel volume head coil. T1-weighted images were obtained in 3 planes using a spin echo sequence (Echo time Additional rodents receiving IP Gd-EBA underwent ex vivo MRI examination of the brain in situ within 2 hours of euthanasia using a 7.0-T small animal MRI scanner (Bruker Biospec 70/30, Ettlingen, Germany). A 38 mm inner diameter quadrature volume coil will be used for RF signal transmission and reception (Litzcage, Doty Scientifi c, Columbia, SC). Sequence acquisition parameters were: T1-weighted using a Rapid Acquisition with Relaxation Enhancement (RARE) pulse sequence with 8 echoes (TR = 1440 ms, TE = 7.5 ms, FOV = 4 cm, matrix = 256 × 256, slice thickness = 0.5 mm, NEX = 8), followed by T2-weighted using a RARE pulse sequence with 8 echoes (TR = 6575 ms, TE = 60 ms, FOV = 4 cm, matrix = 256 × 256, slice thickness = 0.5 mm, NEX = 8).
Blood-brain barrier volumetric quantifi cation and brain pathologic analyses
Following euthanasia, the brain was harvested and digital photographs were obtained of the dorsal surface of the entire brain prior to immersion fi xation in 10% neutral buff ered formalin solution. Th e immersion fi xed intact brain of each rodent was inserted into an adult rodent matrix slicer (Zivix, Instruments, Pittsburg, PA, USA) and digital photographs obtained of the exposed dorsal surface of the brain. Th e brain was then serially sectioned in the transverse plane at 1 mm intervals extending from the olfactory bulbs to the rostral cerebellum, with each individual transverse section paraffi n embedded in a tissue cassette. Th e positions of the transverse sections at which the Gd-EB was fi rst and last visible (the anterior/ rostral and posterior/caudal limits of the z-plane of the BBB disruption) were co-registered to the corresponding channels of the brain matrix and recorded. Transverse brain sections containing EBA within these defi ned rostral and caudal limits were serially sub-sectioned in the transverse plane at 10 μm thickness and 200 μm intervals using a microtome and mounted on charged microscope slides. Digital photomicrographs (Nikon Eclipse
Ni-E, Nikon, Japan) of the fl uorescent volumes intraparenchymal EBA were obtained from all intervening transverse sections using a chargedcoupled device camera with a fi xed aperture (Nikon DS-Fi1c, Nikon, Japan) and an ultraviolet light source. Th e volume of EBA fl uorescence resulting from the transverse image stack from each rat was calculated using the volumetric algorithm on a commercial image analysis system (Stereo Investigator; MBF Bioscience, Williston, VT, USA).
Caspase-3 immunohistochemistry
Transverse brain segments were sectioned at 5 µm and were dried at 37 °C for 1 hour. Deparaffi nization and antigen retrieval were performed in Reveal solution in a decloaking chamber (Biocare Medical, Walnut Creek, CA, USA). Endogenous peroxidase activity was blocked by 30 minute incubation with 5% bovine serum albumin in PBS/0.2% TX-100 (Sigma, St. Louis, MO, USA), followed by two consecutive 10 minute washes in PBS (Sigma). Slides were then incubated overnight at room temperature with polyclonal primary antibody (ab4501, 1:200 dilution; Abcam, Cambridge, MA, USA). Aft er washing twice for 10 minutes with PBS, slides were incubated with prediluted biotinylated goat antirabbit IgGs (Abcam) for 1 hour at room temperature and streptavidin horseradish-peroxidase (Vector, Burlingame, CA, USA). Immunoreactive cells were visualized with fast red chromogen and hematoxylin counterstain (Ventana Medical Syustems, Tucson, AZ, USA). Rat splenic tissue was used for a positive control, and negative controls were treated as described above save for omission of the primary antibody.
Quantitative determination of caspase-3 immunoreactivity
Slides immunohistochemically stained for caspase-3 were examined by an investigator blinded to the experimental treatments. Th e specifi c slice examined in each rat was at the brain level containing the rostral electrode insertion track. Th e examiner was asked to select three 40× magnifi cation random fi elds of view (RFV) from the following four brain regions of each rat from both the treated and contralateral untreated hemispheres of the brain: 1) the superfi cial cerebral cortex in the region of the electrode insertion, 2) the deep termination point of the electrode insertion, representing the electrode tip, 3) the hippocampal CA1 region in the treatment area, and 4) the choroid plexus of the lateral ventricle. Th e RFV from each region and hemisphere were captured with a charge-coupled device digital camera (Nikon DS-Fi1c). Digitized images were optically segmented, using intensity thresholding compared with positive control tissues, in order to allow discrimination of negative from positive (Nikon Elements AR, Nikon Japan). Th is segmentation process allowed for generation of binary images from which the number of positively stained objects and cell nuclei in each RFV could be quantifi ed. For determination of labeling indices for each brain region, at least 500 total cells were counted, and a region-specifi c caspase-3 labeling index (LI) determined as follows: # Caspase 3 immunoreactive cells Caspase -3 LI 1 00
Statistical analyses
One-way ANOVA was used to test for diff erences in the volume of BBB disruption between the VEIN pulse parameters tested, as well as to evaluate diff erences in caspase-3 LI among treatments and brain regions. When results of ANOVA were signifi cant, Tukey post-hoc comparisons were used to examine diff erences among treatment groups. Statistical analyses were performed using commercial soft ware (SAS, version 9.0, Cary, NC, USA) and α = 0.05.
RESULTS
VEIN pulse intracranial procedure
Other than normal respiratory motions occurring under anesthesia, no gross movement was observed during VEIN pulse administration in any © World Scientific Publishing Co./Imperial College Press ARTICLE rodent in the study, and no signifi cant intraoperative complications were noted in any rodent. Additionally, the accelerometer was unable to detect any electrically induced movement (shown for Group 2 in Fig. 1 ). It is important to note that the accelerometer recordings from the high voltage trials (Group 5) were corrupted by electrical noise that fell within the same frequency bandwidth as a typical muscle contraction. Th is eliminated the possibility of fi ltering to isolate potential muscle contractions. In this case, visual observation served as the only means to assess muscle contractions, or lack thereof. Figure 1 also includes samples of the voltage and current measurements from Group 2. At low voltages, the shortest pulse duration achieved was, on average, 850 ns. Th e rise and fall times of these short duration pulses are dependent on the resistance and capacitance of the electrodes and tissue. A 500 ohm resistor was placed in parallel with the load to aid in waveform shaping. In the low voltage experiments, this technique was less successful in producing the desired wave shape. Th e waveform was slightly distorted with the pulses having an extended fall time. As the voltage increased, the pulse duration approached the desired mark of 500 ns per phase ( Table 2) . Th is decrease in pulse duration is likely due to electroporation eff ects decreasing the resistance of the tissue and, in turn, creating a shorter pulse fall time.
VEIN pulse blood brain barrier disruption
Focal disruption of the BBB was achieved in all treated rodents as evidenced by the visualization of EBA or Gd-EBA solutions within treated brain regions on pathological or MRI examinations, and absence of tracer uptake in the sham operated controls and contralateral control hemispheres (Fig. 2) . Th e treatment location is illustrated by Fig. 2d , where the white "x" marks indicate electrode positioning, and the broken line indicates the superfi cial region of BBB disruption as evidenced by EBA uptake. On select MRI scans (Fig. 2b,c,d) , hyperintense areas signifying Gd uptake correspond with regions of EBA on pathologic sections. In the sham operated brain slice (Fig. 2g) , hemorrhage within the electrode insertion track is visible.
The volume of BBB disruption differed significantly among the examined treatment parameters (ANOVA, F(2,4) = 36.44, p = 0.0027). Post-hoc comparisons (Fig. 3) indicated that the mean volume of BBB disruption was significantly smaller in Group 1 (0.51 ± 0.04 cm 3 ) compared to all other groups, and signifi cantly larger in Group 5 (1.09 ± 0.12 cm
3 ) compared to all other groups. Volumes of BBB disruption did not diff er signifi cantly between Groups 2 (0.68 ± 0.03 cm 3 ) and 3 (0.68 ± 0.09 cm 
Histopathological analysis of VEIN pulse delivery
No microscopic or gross abnormalities were detected in unoperated contralateral control brains. In the treated cerebral hemispheres of Groups 1 and 6, lesions were limited to the physical displacement of the brain tissue in the trajectory of the electrode insertion, with occasional foci of hemorrhage noted on the pial surface or within the electrode track (Fig. 4a,f ) . In Groups 2, 3, and 4, the laminar organization of the brain remained intact, but there was mild vacuolization of the neuropil in regions of BBB disruption, as well as foci of neurons, glia, vascular endothelium, and choroid plexus epithelium demonstrating cytoplasmic condensation, nuclear pyknosis, and apoptotic body formation (Fig. 4b-d) . Th e brains of Group 5 rats displayed severe cytoarchitectural disruption, perivascular infl ammation, and coagulative brain necrosis in treated regions (Fig. 4e) . 
Caspase-3 immunohistochemistry
Group 3 caspase-3 LI was signifi cantly (p < 0.01) higher than all other groups in each of the superfi cial cortical, deep cortical, and choroid plexus brain regions (Figs. 5, 6 ). Marked caspase-3 immunoreactivity was seen in the SC, DC and CP regions of Group 3 ( Fig. 5f,j,n) , with numerous caspase-3 immunoreactive neurons adjacent to the electrode insertion track in the DC region (Fig. 5j) . Th e caspase-3 LI of groups 2, 4, and 5 were also observed to be signifi cantly greater than sham operated or untreated controls in at least one area among the superfi cial cortical, deep cortical, and choroid plexus brain regions. Th ere were no signifi cant diff erences observed in the casapse-3 LI between Group 1, 6, or untreated control hemispheres for any of the 4 brain regions examined. No diff erences were noted between any group in the caspase-3 LI of the hippocampal CA1 region (Fig. 6a) .
DISCUSSION
Sub-lethal BBB disruption was achieved immediately following treatment at the lowest energy setting (Group 1), which consisted of 300 bursts with an amplitude of 250 V/cm. Each burst consisted of 200 pulses with a duration of 850 ns for a total on-time of 170 μs. Relative to the size of the brain, the volume of BBB disruption was substantial (0.51 cm 3 ). Other than physical damage due to the electrode insertion, there was no noticeable neuroinfl ammation or cell death when capase-3 activity from Group 1 was compared to Group 6 controls or the unoperated control. It is important to note that cell morphologic criteria were used to defi ne dead cells and caspase-3 was used to corroborate those fi ndings. Future work should include later time points to investigate the possibility of delayed eff ects and the reversibility of the BBB disruption.
As the number of bursts containing 500 ns pulses (programmed) was increased (Groups 2 and 3), evidence of cell death was noted by cytoplasmic condensation, nuclear pyknosis, and apoptotic body formation. Th e same is true when the individual pulse duration was increased to 2 μs, while programming the same on-time (Group 4). Interestingly, Group 3 exhibited markedly greater caspase-3 activity than Group 4. We hypothesize that this eff ect could be due to the ability of sub-microsecond pulses to exert greater infl uence on intracellular structures 23, 24 . Overall, increasing the number of bursts above 600, or increasing the programmed pulse duration above 500 ns did not signifi cantly alter the volume of BBB disruption. Th is suggests that the eff ect has reached a plateau, and additional energy is deleterious to cell viability. In Group 5, necrosis was evident without a signifi cant increase in caspase-3 expression. Th is fi nding is comparable to that found by Rossmeisl et al., where unipolar IRE pulses applied at similar electric fi elds caused no signifi cant or specifi c immunoreactivity to Bcl-2, caspase-3, or caspase-9 within the lesions 25 . Th e dissipated energy density for each treatment ( Table 2) can be calculated by:
where σ is the conductivity of the tissue, E is the electric fi eld, and t is the total energized time (burst on-time × number of bursts). Th e conductivity was estimated to be 0.18 S/m according to data generated by Gabriel et al. for gray matter at 1 MHz
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. Assuming a perfectly insulative unitary volume, the temperature change can then be estimated according to: where ρ and c are the density and specifi c heat capacity of the tissue, respectively. Th ese values are chosen to be the same as water (ρ = 4.184 J/(gK), c = 1 × 10 6 g/m 3 ). For comparison, the calculations were also made for an IRE treatment, in which it was shown that thermal eff ects were negligible. From this comparison, we conclude that the eff ects seen in Groups 1 through 4 were non-thermal in nature. Th e comparatively higher energy delivery in Group 5 resulted in thermal damage, including coagulative necrosis near the electrodes where the electric fi eld is elevated. However, these temperature predictions are conservative in that they assume the entire tissue is uniformly exposed to the electric fi eld, and they do not account for heat dissipation between the pulses and heat convection from the surface of the tissue. Future work should include monitoring of temperature during treatment to confi rm the predictions.
Reversible electroporation combined with chemotherapeutic agents, or electrochemotherapy, has proven to be eff ective in treating brain tumors in a rat model with minimal side eff ects 27, 28 . In this pre-clinical work, the chemotherapeutic agent bleomycin was administered directly into the tumor before applying electric pulses, which circumvented the BBB. It was later noted that a potential usage of electrochemotherapy could be to treat the infiltrative margins of a tumor aft er surgical debulking 29 , as those regions are well-vascularized with an intact BBB. In a study conducted by Hjouj et al., BBB disruption was evaluated for 50 to 90 unipolar pulses as short as 50 μs 30 . When the pulse amplitude was between 330 V/cm and 500 V/cm, it was concluded that transient BBB disruption without permanent tissue damage was the result of reversible electroporation. Th is is similar to the fi nding in Ref. 18 that electroporation is predominantly reversible at electric fi eld strengths below 400 V/cm in normal brain.
Here, BBB disruption is observed at an even lower electric field (250 V/cm) when a greater number of bipolar bursts are applied. Th erefore, it is feasible that the mechanism of opening the BBB does not rely completely on reversible electroporation. One possible explanation is that the presence of tight junctions increases the transendothelial electrical resistance of the BBB 31 . As a result, there is a large voltage drop across the endothelial cells, and it is possible that even low voltages produce high electric fi elds that compromise the integrity of tight junctional proteins. BBB disruption without electroporation has been shown in vitro when performing protocols for deep brain stimulation across endothelial cell monolayers 32 . Th e waveforms were bipolar with individual pulse durations of 90 μs, and they were applied continuously for 5 minutes at 2.5 V/cm. Th e in vivo microscopic electric fi eld distribution is complicated, and one cannot rule out the possibility of other explanations, including low level heating due to the high electrical conductivity of the blood, without further experimentation.
Researchers have investigated BBB disruption as a health hazard in response to electromagnetic radiation 33 . When 200, 14 ns pulses were applied at 2000 V/cm, increased BBB permeability was noted along with altered localization and decreased levels of the tight junctional protein ZO-1. Magnetic fi elds have also been used to disrupt the BBB when combined with magnetic nanoparticles. In the presence of an alternating magnetic fi eld, the iron oxide nanoparticles release heat and cause localized hyperthermia (≥ 38°C for 30 minutes) that is thought to transiently open the BBB 34 . Th ese particles can also be steered to the target location using magnetic resonance. Additionally, activation of photosensitizing agents with laser light (600-700 nm) has been shown to disrupt tumor vasculature 22, 35 . Th is aff ect can also be targeted to the BBB and reversible at low fl uence levels (9 J) 35 . Even at the highest energy setting (Group 5), no muscle contractions were observed. Th is serves as confi rmation of our previous results, which show that bipolar pulses reduce the electric fi eld threshold for stimulating an action potential 21 . When very short pulses are used, there is a latency period between the off set of the pulse and the rising phase of the action potential. Reversing the pulse polarity within the latency period can inhibit action potential generation 36 . An additional benefi t to very short, bipolar pulses, it that they have the potential to create more uniform treatment volumes within heterogeneous tissues 37 . Th is could prove benefi cial in treatment planning for tumor ablation and BBB disruption, as the brain is composed of multiple tissue types with varying electrical properties.
CONCLUSION
Th e VEIN pulse platform is a feasible technique for performing sub-lethal BBB disruption. Th e results presented herein warrant future studies directed at optimizing the range of eff ective pulse parameters and exploring the exact mechanism of action. If translated clinically, this treatment has the potential to enhance drug delivery in the brain for treating a wide range of disease including brain cancer, Parkinson's disease, and Alzheimer's disease. Additionally, with respect to brain cancer, there is the option of performing a combinatorial technique that relies on an initial set of lethal pulse parameters to destroy the primary tumor followed by a sub-lethal set of pulse parameters to improve drug diffusion to the infiltrative cells beyond the tumor margin. 
